Cargando…
Acute Sulfonylurea Therapy at Disease Onset Can Cause Permanent Remission of K(ATP)-Induced Diabetes
OBJECTIVE: Neonatal diabetes mellitus (NDM) can be caused by gain-of-function ATP-sensitive K(+) (K(ATP)) channel mutations. This realization has led to sulfonylurea therapy replacing insulin injections in many patients. In a murine model of K(ATP)-dependent NDM, hyperglycemia and consequent loss of...
Autores principales: | Remedi, Maria Sara, Agapova, Sophia E., Vyas, Arpita K., Hruz, Paul W., Nichols, Colin G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178299/ https://www.ncbi.nlm.nih.gov/pubmed/21813803 http://dx.doi.org/10.2337/db11-0538 |
Ejemplares similares
-
Genetic Reduction of Glucose Metabolism Preserves Functional β-Cell Mass in K(ATP)-Induced Neonatal Diabetes
por: Yan, Zihan, et al.
Publicado: (2022) -
Remission of Severe Neonatal Diabetes With Very Early Sulfonylurea Treatment
por: Marshall, Bess A., et al.
Publicado: (2015) -
Congenital Hyperinsulinism and Glucose Hypersensitivity in Homozygous and Heterozygous Carriers of Kir6.2 (KCNJ11) Mutation V290M Mutation: K(ATP) Channel Inactivation Mechanism and Clinical Management
por: Loechner, Karen J., et al.
Publicado: (2011) -
Pancreatic β-Cells From Mice Offset Age-Associated Mitochondrial Deficiency With Reduced K(ATP) Channel Activity
por: Gregg, Trillian, et al.
Publicado: (2016) -
Altered Phenotype of β-Cells and Other Pancreatic Cell Lineages in Patients With Diffuse Congenital Hyperinsulinism in Infancy Caused by Mutations in the ATP-Sensitive K-Channel
por: Salisbury, Rachel J., et al.
Publicado: (2015)